Non-Opioid EXPAREL Shows Health, Economic Benefits
Pooled data show that EXPAREL® (bupivacaine liposome injectable suspension) slashes opioid consumption, risk of opioid- related side effects, length of postsurgery hospital stay, and cost.
Pooled data show that EXPAREL® (bupivacaine liposome injectable suspension) slashes opioid consumption, risk of opioid- related side effects, length of postsurgery hospital stay, and cost.
The ready-to-use liquid botulinum toxin treatment requires no reconstitution. Phase III trials showed improvements in frown lines, with some patients maintaining results for up to six months.